Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 20
- Q2 2023, +1 vs. previous quarter
- 13F value
- $269.5K
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding ACGN, Q2 2023
No superinvestor reported holding ACGN at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by Aceragen, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Gowen MaxineDirector | SSale | −51 | $0.51 | −$26.01 | −100.0%0 after | |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Milano VincentDirector | SSale | −3.28K | $0.53 | −$1.74K | −26.8%8.99K after | |
| Jul 19, 2023 (view filing)4:05 PM ET | May 17 | 63 daysLate | Zein Youssef El and 4 others10% Owner | PPurchase | +27.0K | $1.42 | +$38.3K | +18.8%170.7K after | |
| Jul 19, 2023 (view filing)4:05 PM ET | Jul 12-13 | 7 daysLate | Zein Youssef El and 4 others10% Owner | SSale | −5.82K | $1.56 | −$9.10K | −3.4%164.9K after | 2 lots |
| May 18, 2023 (view filing) | May 15-17 | 3 daysLate | Chopra Atul10% Owner | SSaleCommon Stock, $0.001 per share | −135.7K | $1.44 | −$195.4K | −10.1%1.21M after | 25 lots |
| May 18, 2023 (view filing) | May 12 | 6 daysLate | Chopra Atul10% Owner | SSaleCommon Stock, $0.001 per share | −81.5K | $1.56 | −$126.9K | −5.7%1.34M after | 21 lots |
| May 18, 2023 (view filing) | May 11 | 7 daysLate | Chopra Atul10% Owner | SSaleCommon Stock, $0.001 per share | −47.2K | $1.84 | −$86.9K | −3.2%1.42M after | 20 lots |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Kirby John J.CHIEF FINANCIAL OFFICER | PPurchase | +10.0K | $0.62 | +$6.20K | +36.2%37.6K after |
Top 10 13F holders, Q2 2023
The largest institutional positions in Aceragen, Inc. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 74,170 | $120.9K | 0.00% | −1,888−2.5% | Reduced |
| BlackRock Inc. | 25,214 | $41.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,342 | $38.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 11,653 | $19.0K | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 11,521 | $18.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,126 | $11.6K | 0.00% | +971+15.8% | Added |
| Morgan Stanley | 4,860 | $7.92K | 0.00% | +5+0.1% | Added |
| Hollencrest Capital Management | 3,999 | $6.52K | 0.00% | −3,588−47.3% | Reduced |
| UBS Group AG | 1,709 | $2.79K | 0.00% | +1,645+2,570.3% | Added |
| Group One Trading, L.P. | 1,047 | $1.71K | 0.00% | −196−15.8% | Reduced |